Completed NA INTERVENTIONAL 2-arm NCT01320852

PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC)

PET Scan as a Screening Tool for Liver Transplant in Patients With HCC

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Interventions PET Scan

Updated 6 times since 2017 Last updated: Oct 24, 2013 Started: Dec 31, 2010 Primary completion: Sep 30, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hepatocellular Carcinoma and is currently completed. McGill University Health Centre/Research Institute of the McGill University Health Centre leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Oct 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Pfizer

Data source: McGill University Health Centre/Research Institute of the McGill University Health Centre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada